C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2006
11/16/2006	US20060258602 Site-specific gene conversion promoter and gene therapeutic
11/16/2006	US20060258601 Formulation for inwardly transferring nucleic acids into eucaryotic cells
11/16/2006	US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy
11/16/2006	US20060258585 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/16/2006	US20060258574 Novel compositions and methods for the treatment of psoriasis
11/16/2006	US20060258566 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
11/16/2006	US20060258554 Bgl6 beta-glucosidase and nucleic acids encoding the same
11/16/2006	US20060258007 Regulated vectors for selection of cells exhibiting desired phenotypes
11/16/2006	US20060258006 Transducing a cell with a retroviral vector comprising a nucleotide sequence encoding lentiviral Gag-Pol, wherein the retroviral vector is of different viral origin than a lentivirus, and wherein the lentiviral packaging cell stably produces lentiviral Gag-Pol continuously for at least 3 months
11/16/2006	US20060258005 Novel virus vector
11/16/2006	US20060258002 Scanned image alignment systems and methods
11/16/2006	US20060257989 Truncated aggrecanase molecules
11/16/2006	US20060257988 Chlorohydrin and hydroxycarboxylic ester asymmetric hydrolase gene
11/16/2006	US20060257983 Metabolically engineered micro-organisms having reduced production of undesired metabolic products
11/16/2006	US20060257979 Using recombinant microorganisms in which the open reading frame (ORF) designated ytfQ is enhanced in particular overexpressed; fermentation
11/16/2006	US20060257978 Deracemisation of amines
11/16/2006	US20060257976 Methods and kits for propagating and evolving nucleic acids and proteins
11/16/2006	US20060257975 Encoded by nucleic acid of given sequence; hybridizes to complement of nucleic acid; use as molecular weight markers,
11/16/2006	US20060257974 Vaccinia virus vector comprising a nucleic acid encoding a fusion protein amino acid sequence consisting of Vif, Vpr, Vpu, Vpx, Rev, Tat, and Nef; genetic vaccines for treating viral diseases
11/16/2006	US20060257971 Antibodies to pro1561 polypeptide
11/16/2006	US20060257970 Human HAC3
11/16/2006	US20060257965 Extracellular matrix signalling molecules
11/16/2006	US20060257960 Method of estimating drug metabolic activity by analyzing mutations in glucuronosyl transferase gene
11/16/2006	US20060257959 Glucose dehydrogenase
11/16/2006	US20060257953 Artificial antibody polypeptides
11/16/2006	US20060257940 Transformed Shigella
11/16/2006	US20060257937 Focused libraries of genetic packages
11/16/2006	US20060257928 ANGE gene in atopy
11/16/2006	US20060257923 capable of processing intron-containing eukaryotic genes, and also can carry out post-translational processing steps such as glyclosylation and protein folding
11/16/2006	US20060257918 Polynucleotide encoding a novel human G-protein coupled receptor variant of the relaxin receptor HGPRBMY5v1, and variants thereof
11/16/2006	US20060257916 Testing of an organism and correlating the results with a unique marker (single nucleotide polymorphism or short tandem repeats) that identifies the sample; contacting a target sequence with oligonucleotide probes, interrogating the hybridization complexes, decoding
11/16/2006	US20060257912 Methods and sequences to suppress primate huntington gene expression
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257910 aligning a protein on a surface; immobilization; Preparing solid support comprising immobilized proteins for detecting, measuring, separating and/or assaying DNA or proteins in a sample
11/16/2006	US20060257906 Compositions comprising a library of analytes for detection, quantification and analyses
11/16/2006	US20060257897 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/16/2006	US20060257889 Ribonuclease resistant RNA preparation and utilization
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257880 Gastric and prostate cancer associated antigens
11/16/2006	US20060257878 Nucleic acid amplifier and method of nucleic acid amplification
11/16/2006	US20060257867 Ghrelin binding nucleic acids
11/16/2006	US20060257856 Heterodimeric receptor libraries using phagemids
11/16/2006	US20060257852 Severe acute respiratory syndrome coronavirus
11/16/2006	US20060257544 Method for the prevention or reduction of haze in beverages
11/16/2006	US20060257465 Methods for preparation of lipid-encapsulated therapeutic agents
11/16/2006	US20060257464 Comprises cationic phospholipid derivatives which complex with DNA
11/16/2006	US20060257424 Having mutation in viral nucleic acid encoding viral protein 2; bird and chicken vaccines
11/16/2006	US20060257418 Vaccine
11/16/2006	US20060257417 Vaccine antigens of Moraxella
11/16/2006	US20060257416 Materials and methods for improved vaccination
11/16/2006	US20060257413 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/16/2006	US20060257406 Immunoglobulin variable domain; tumor necrosis factor; competitve binding; surface plasmon resonance
11/16/2006	US20060257387 Sugar chain synthase gene
11/16/2006	US20060257382 Corneal cells expressing active agents and methods of use thereof
11/16/2006	US20060257380 Use of sirnas for gene silencing in antigen presenting cells
11/16/2006	US20060257371 Adenoviral vectors for treating diseases
11/16/2006	US20060257370 Adenoviral vectors for treating diseases
11/16/2006	US20060257369 Therapeutic regimen for treating cancer
11/16/2006	US20060257367 Tumour-cell specific gene expression and its use in cancer therapy
11/16/2006	US20060257366 Chimeric glycoproteins and pseudotyped lentiviral vectors
11/16/2006	US20060257364 Materials and methods for inhibition of IgE production
11/16/2006	DE102005028295A1 New polynucleotide encoding a protease active at low temperature, for use e.g. in cleaning, pharmaceutical and cosmetic compositions and for eliminating biofilms
11/16/2006	DE10010282B4 Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben Process for detection of cytosine methylation in DNA samples
11/16/2006	CA2651376A1 Method for diagnosis and treatment of a mental disease
11/16/2006	CA2608643A1 Gene-based algorithmic cancer prognosis
11/16/2006	CA2608316A1 Vaccine composition
11/16/2006	CA2608315A1 Use of a new gene coding for a new member of the mcm2-8 family in pharmaceutical compositions
11/16/2006	CA2608103A1 Screening assays for compounds regulating dj-i expression
11/16/2006	CA2608068A1 Novel steroid 5 .alpha.-reductase
11/16/2006	CA2608058A1 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
11/16/2006	CA2607678A1 Production of animal proteins in n-glucosaminyl transferase i-deficient plants
11/16/2006	CA2607645A1 Method for transformation using mutant acetolactate synthase gene
11/16/2006	CA2607595A1 Recombinant n-glycosylated proteins from procaryotic cells
11/16/2006	CA2607581A1 Methods and compositions for detecting immune responses
11/16/2006	CA2607330A1 Plants containing a heterologous flavohemoglobin gene and methods of use thereof
11/16/2006	CA2607263A1 Expression cassettes for seed-preferential expression in plants
11/16/2006	CA2607218A1 Use of mapc or progeny therefrom to populate lymphohematopoietic tissues
11/16/2006	CA2607170A1 Method for the isolation of spiroplasma in mammals
11/16/2006	CA2607147A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
11/16/2006	CA2607142A1 Personal care compositions and methods for their use
11/16/2006	CA2606287A1 Peptide
11/16/2006	CA2605324A1 Targeted gene addition in stem cells
11/16/2006	CA2586250A1 Compositions for treating respiratory viral infections and their use
11/15/2006	EP1721991A1 Method of detecting nucleic acid and utilization thereof
11/15/2006	EP1721989A1 Method of preparing menadione with a recombinant micro-organism
11/15/2006	EP1721987A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
11/15/2006	EP1721986A1 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
11/15/2006	EP1721985A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles
11/15/2006	EP1721984A2 Method for cloning and expression of the NheI restriction endonuclease in E. coli
11/15/2006	EP1721983A1 Triterpene hydroxylase
11/15/2006	EP1721982A1 Chimeric lyssavirus nucleic acids and polypeptides
11/15/2006	EP1721981A1 Recombinant varicella-zoster virus
11/15/2006	EP1721980A1 Method of producing recombinant sucrose synthase, use thereof in the production of sucrose-determination kits, method of producing adpglucose and method of obtaining transgenic plants having leaves and reserve organs which accumulate a high concentration of adpglucose and starch
11/15/2006	EP1721979A1 Compositions and methods for increasing bone mineralisation
11/15/2006	EP1721978A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof
11/15/2006	EP1721977A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
11/15/2006	EP1721976A1 Modified promoter
11/15/2006	EP1721975A1 Method of detecting and identifying gram-negative obligative anaerobic bacterium
11/15/2006	EP1721974A1 Competitive n-hybrid system
11/15/2006	EP1721973A1 Mutant bacterium belonging to the genus bacillus

1 ... 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 ... 4023